Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Saeed, D; Loforte, A; Morshuis, M; Schibilsky, D; Zimpfer, D; Riebandt, J; Pappalardo, F; Attisani, M; Rinaldi, M; Haneya, A; Ramjankhan, F; Donker, DW; Jorde, UP; Pacini, D; Otto, W; Stein, J; Lewin, D; Jawad, K; Wieloch, R; Ayala, R; Cremer, J; Borger, MA; Lichtenberg, A; Gummert, J; Potapov, E, , Durable, MCS, after, ECLS, Study, Group.
Stroke Complications in Patients Requiring Durable Mechanical Circulatory Support Systems After Extracorporeal Life Support.
ASAIO J. 2023; 69(2):145-150
Doi: 10.1097/MAT.0000000000001732
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Zimpfer Daniel
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Stroke is one of the leading complications following durable mechanical circulatory support (MCS) implantation. The aim of this multicenter study was to investigate stroke complications in patients requiring durable MCS following extracorporeal life support (ECLS). Data of 11 high volume MCS centers were collected and evaluated to identify patients who underwent durable MCS implantation after ECLS support between January 2010 and August 2018. The primary outcome was stroke following durable MCS implantation. Univariate and multivariate logistic regression analyses were performed to determine predictors of stroke. Overall, 531 patients met the inclusion criteria. Only patients who were supported with continuous flow pumps were included in this study accounting for 495 patients (median age 54 years old [interquartile range 47-60]). A total of 136 patients (27%) developed postoperative stroke on device during the follow-up (48% ischemic and 52% hemorrhagic) after a median durable MCS support of 320 [32-1,000] days, accounting for 0.17 events per patient-year. Of 133 patients with known date of stroke, a total of 47 (10%) developed stroke during the first 30 days (64% ischemic and 36% hemorrhagic), and 86 patients developed stroke after 30 days (38% ischemic and 62% hemorrhagic) of durable MCS support (late stroke). Survival rate was significantly lower in patients with hemorrhagic stroke ( p = 0.00091). Stroke appears to be a common complication in patients transitioned to durable MCS support after ECLS. Hemorrhagic stroke is a more common type of late stroke and is associated with inferior outcomes.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Middle Aged - administration & dosage
- Extracorporeal Membrane Oxygenation - adverse effects
- Hemorrhagic Stroke - etiology
- Heart-Assist Devices - adverse effects
- Retrospective Studies - administration & dosage
- Survival Rate - administration & dosage
- Treatment Outcome - administration & dosage
- Heart Failure - surgery
- Find related publications in this database (Keywords)
- stroke
- mechanical circulatory support system
- ECLS
- ECMO